NCT00755924

Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: HealthPartners Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.

Conditions

• Cholesterol, HDL

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Vinegar	Apple cider vinegar 2 TBlsp/day
OTHER	Placebo	Water placebo colored with balsamic vinegar

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-08-01
• Completion: 2010-07-01
• First posted: 2008-09-19
• Last updated: 2015-11-26

Locations

1 site across 1 country: United States